Gastric emptying in healthy volunteers after multiple doses of levodopa
- PMID: 1768561
- PMCID: PMC1368548
Gastric emptying in healthy volunteers after multiple doses of levodopa
Abstract
1. Oral levodopa frequently produces an episodic delay in gastric emptying which leads to multiple peak concentrations of the drug in plasma. We have studied the effects of multiple dosing of levodopa on gastric emptying and levodopa absorption in eight healthy young volunteers in a randomised two-way cross-over study. 2. The plasma concentration-time curves for levodopa were measured after three oral doses of 125 mg given at 2 h intervals and compared with the concentration-time curve for levodopa following administration of two doses of placebo and a single oral dose of 125 mg. 3. A low incidence of multiple peak plasma concentrations of levodopa was detected after all doses of levodopa. The area under the plasma concentration-time curves (AUC) for the final dose of levodopa (150.8 +/- 22.0 micrograms ml-1 min) was lower than for the two preceding doses (205.7 +/- 41.8 and 199.5 +/- 51.8 micrograms ml-1 min) but not different from that of the single dose given at the same time of day (141.7 +/- 29.1 micrograms ml-1 min). This indicates that the lower AUC of the final dose of levodopa was related to the time of administration and not a result of the two preceding doses. 4. The absence of any significant effects of preceding doses of levodopa on gastric emptying was confirmed a) by co-administration of soluble paracetamol, as a marker of gastric emptying, with the second dose of levodopa or placebo and b) by co-administration of radiolabelled DTPA and gamma-camera imaging with the final dose of levodopa on the multiple dosing day and the single dose of levodopa on the placebo day.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
The effects of co-administration of benzhexol on the peripheral pharmacokinetics of oral levodopa in young volunteers.Br J Clin Pharmacol. 1996 Apr;41(4):331-7. doi: 10.1046/j.1365-2125.1996.32311.x. Br J Clin Pharmacol. 1996. PMID: 8730980 Free PMC article. Clinical Trial.
-
Concurrent administration of donepezil HCl and levodopa/carbidopa in patients with Parkinson's disease: assessment of pharmacokinetic changes and safety following multiple oral doses.Br J Clin Pharmacol. 2004 Nov;58 Suppl 1(Suppl 1):41-9. doi: 10.1111/j.1365-2125.2004.01799.x. Br J Clin Pharmacol. 2004. PMID: 15496222 Free PMC article. Clinical Trial.
-
The influence of levodopa on gastric emptying in man.Br J Clin Pharmacol. 1990 Jan;29(1):47-53. doi: 10.1111/j.1365-2125.1990.tb03601.x. Br J Clin Pharmacol. 1990. PMID: 2404503 Free PMC article.
-
Guide for judicious use of the paracetamol absorption technique in a study of gastric emptying rate of liquids.J Gastroenterol. 1998 Dec;33(6):785-91. doi: 10.1007/s005350050177. J Gastroenterol. 1998. PMID: 9853549 Review.
-
Pharmacokinetics of levodopa.Clin Neuropharmacol. 1984;7(1):35-49. doi: 10.1097/00002826-198403000-00002. Clin Neuropharmacol. 1984. PMID: 6367973 Review. No abstract available.
Cited by
-
Ex Vivo and In Vivo Characterization of Interpolymeric Blend/Nanoenabled Gastroretentive Levodopa Delivery Systems.Parkinsons Dis. 2017;2017:7818123. doi: 10.1155/2017/7818123. Epub 2017 Apr 26. Parkinsons Dis. 2017. PMID: 28529814 Free PMC article.
-
Parkinson disease and the gut: new insights into pathogenesis and clinical relevance.Nat Rev Gastroenterol Hepatol. 2020 Nov;17(11):673-685. doi: 10.1038/s41575-020-0339-z. Epub 2020 Jul 31. Nat Rev Gastroenterol Hepatol. 2020. PMID: 32737460 Review.
-
Pharmacokinetic optimisation in the treatment of Parkinson's disease.Clin Pharmacokinet. 1996 Jun;30(6):463-81. doi: 10.2165/00003088-199630060-00004. Clin Pharmacokinet. 1996. PMID: 8792058 Review.
-
Preventive effect of rikkunshito on gastric motor function inhibited by L-dopa in rats.Peptides. 2014 May;55:136-44. doi: 10.1016/j.peptides.2014.02.011. Epub 2014 Mar 11. Peptides. 2014. PMID: 24631952 Free PMC article.
-
Pharmacokinetic behaviour of levodopa and 3-O-methyldopa after repeat administration of levodopa/carbidopa with and without entacapone in patients with Parkinson's disease.J Neural Transm (Vienna). 2006 Oct;113(10):1441-8. doi: 10.1007/s00702-006-0442-5. Epub 2006 Apr 11. J Neural Transm (Vienna). 2006. PMID: 16604302 Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources